These Three Toilets Detection Health Technologies Will Be Clinically Tested In The US, Israel And Japan

Israeli digital health startup OutSense has been awarded a number of patents for key innovations in IoT technology, according to foreign media reports on 23 ሰኔ. The technology gains life-saving medical insights by analysing human excrement. ኩባንያው የህክምና መጸዳጃ ቤቱን ዳሳሽ የሚሸፍኑ ሶስት ተከታታይ የፈጠራ ባለቤትነት ማረጋገጫዎችን አቅርቧል.

Three Toilets Detection Health Technologies

The first OutSense toilets detection health technologies is for the detection of blood hidden in the toilet bowl. This OutSense device uses reflected light from the toilet to determine the optical signature of hidden blood in faeces. Patents for this technology have been granted in the US, አውሮፓ, ጃፓን እና ቻይና.

A second toilets detection health technologies has been granted in Europe and applications for this patent are pending in other countries. It allows effective analysis of the many components of faeces and the spatial distribution of blood traces. On the basis of this analysis, የ OutSense ቴክኖሎጂ በጨጓራና ትራክት በኩል ያለውን የደም ምንጭ መለየት ይችላል.

A third patent is pending for a technology that detects the dehydrated composition of urine through the analysis of urine and faeces.

እንደ OutSense ዋና ስራ አስፈፃሚ ይፋት ስያሎም, who predicts that “ከዲጂታል መድሃኒት ፍንዳታ ጋር, this kind of monitoring will become the norm”, OutSense says that the technology already approved and pending approval will provide broad protection for a person’s health by non-invasively extracting faeces and hidden blood from the urine. Hidden blood is essential for detecting colorectal cancer, የሆድ እብጠት በሽታ እና የሽንት በሽታ.

Its solution consists of a multispectral optical sensor, የዋይፋይ ግንኙነትን የሚያካትት የብርሃን ምንጭ እና ራሱን የቻለ የማጣሪያ መሳሪያ. The device scans human excrement, identifies the optical footprint of faecal and urine components, sends the data to an AI-based cloud analysis and then provides indications of various diseases with great precision.

OutSense has developed tools to diagnose abnormalities in human excreta. ከደም ናሙና የተገኘ መረጃ, ከደም መፍሰስ ወደ ማስወጣት ጊዜ ከተጨማሪ ትንታኔ ጋር ተጣምሮ, ስለ ደም መፍሰስ የፓቶሎጂ ዝርዝር መረጃ ይሰጣል. Its specific patterns can determine whether the bleeding is from a fissure or haemorrhoid, from a polyp, a tumour or from an ulcer.

At the beginning of June, OutSense ያንን ኮሙኒኬር አስታውቋል, በላይ ጋር አንድ ትልቅ የጤና እንክብካቤ ኩባንያ 90 healthcare facilities in the US, በዚህ አመት ቴክኖሎጂውን መሞከር ይጀምራል. ከዚህ አብራሪ በተጨማሪ, OutSense also plans to conduct clinical trials in Israel and Japan.